Clinical Trial: A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698899) titled 'A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)' on July 06.

Brief Summary: The purpose of this study is to find out whether 177Lu-DPTA-omburtamab is a safe treatment for children and adolescents with recurrent/refractory medulloblastoma or another type of cancer with CNS metastases.

Study Start Date: July 02

Study Type: INTERVENTIONAL

Condition: Recurrent Medulloblastoma Refractory Medulloblastoma CNS Metastases Central Nervous System Metastasis

Intervention: BIOLOGICAL: 25 mCi 177Lu- DTPA-omburtamab

The dose of DTPA-omburtamab will ...